FDA Inspection
Synthon Hispania S.L.Synthon Hispania S.L. – FDA Inspection, Mar 28, 2019
Record Details
This FDA Inspection record concerns Synthon Hispania S.L., with an inspection on March 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA McCulloughJ (Issuing Officer)
View Company Profile
ID · 2bdfcfb1-8cd6-4bb0-99e1-8a6d68ce02f9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1095527
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Synthon Hispania S.L.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 20, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 1, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Synthon Hispania S.L.
- FDA Inspection 1257791 - 2023-04-20
- FDA Inspection 887033 - 2014-05-23
- FDA Inspection 695164 - 2010-10-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.